TEACHABLE MEDICAL NEWS

CREATED BY ELEASYS LLC

Tag: GLP-1

How can the injectable medication Ozempic get TikTok users excited about weight loss?

By

On August 17, 2022

In digestive system, endocrine system, nervous system

TeachableMedicalNews article 08182022

Teachable moment in classrooms:

  1. endocrine system chapter – hormones deliver instructions through receptors
  2. nervous system – brain chapter – location and function of hypothalamus in the diencephalon
  3. digestive system chapter – cells of the small intestine make hormones that control appetite

The news item:  Recently the following report appeared:

https://www.yahoo.com/now/ozempic-touted-tiktok-weight-loss-185703991.html

 

 

the article stated that Ozempic is a prescription medication for type II diabetes, that Ozempic makes the pancreas to make more insulin, and that the weight loss is caused through the suppression of the appetite.

So, Why Do I Care??  One reason for caring is that it is unusual to see a side effect of a prescription drug that is a desirable side effect. The other reason to be interested is that we see an example of the sensitivity of the brain to hormones made in the small intestine. It becomes even more interesting, because it looks that the fight against the obesity epidemic just gained a new tool. About 50% of the adults and 25% of children in the USA are obese. Lowering the prevalence of obesity by weight loss could lower the occurrence of heart attacks, strokes, and several cancers.

Plain English, Please!!! First, let’s talk about what is Ozempic. The protein hormone GLP-1 (glucagon like peptide) is the active ingredient in Ozempic. GLP is a natural product of the cells in the human

Read More

How can the injection of a non-insulin medication help type 2 diabetes patients?

By

On January 17, 2021

In endocrine system, metabolism

TeachableMedicalNews article 01172021

Teachable moment in classrooms:

  1. endocrine system chapter – insulin production by beta cells
  2. endocrine system chapter – action of hormones through receptors
  3. endocrine system chapter – action of hormones inside target cells
  4. metabolism chapter – effect of insulin on glucose utilization by body cells

The news item:  Recently a new report appeared about the diabetes treatment drug Trulicity:

FDA approves Eli Lilly’s Trulicity to reduce cardiovascular risks in type 2 diabetic patients

Eli Lilly and Co said on Friday the U.S. Food and Drug Administration has approved Trulicity for reducing cardiovascular risk factors in type 2 diabetic patients. The approval makes Trulicity the first and only type 2 diabetes drug approved to reduce heart related risks in adults with and without established cardiovascular disease, the company said in a statement.

The article states that the type 2 diabetes treatment drug was approved for reducing heart disease risk as well.

So, Why Do I Care??  About 30 million people in the US has type 2 diabetes. The disorder causes about 80,000 deaths yearly. In addition, there is a yearly $327 billion cost from lost productivity and medical cost that includes treatment for diabetic vision loss and diabetic nephropathy. Diabetes also causes heart damage. New treatments have a chance to reduce deaths and lost working hours.

Plain English, Please!!!

First, let’s talk about type 2 diabetes. Diabetes, in general, is a disorder where blood sugar (glucose) level is higher than normal for long periods of time. The continuous high blood glucose level damages small

Read More

Powered by WordPress & Theme by Anders Norén